Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease

Although the presence of nonalcoholic fatty liver disease (NAFLD) is known to be related to subclinical atherosclerosis, the relationship between the severity of NAFLD and subclinical atherosclerosis is not clear. This study aimed to clarify the factors related to subclinical arteriosclerosis, inclu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2019-11, Vol.14 (11), p.e0224184-e0224184
Hauptverfasser: Arai, Taeang, Atsukawa, Masanori, Tsubota, Akihito, Kawano, Tadamichi, Koeda, Mai, Yoshida, Yuji, Tanabe, Tomohide, Okubo, Tomomi, Hayama, Korenobu, Iwashita, Ai, Itokawa, Norio, Kondo, Chisa, Kaneko, Keiko, Kawamoto, Chiaki, Hatori, Tsutomu, Emoto, Naoya, Iio, Etsuko, Tanaka, Yasuhito, Iwakiri, Katsuhiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0224184
container_issue 11
container_start_page e0224184
container_title PloS one
container_volume 14
creator Arai, Taeang
Atsukawa, Masanori
Tsubota, Akihito
Kawano, Tadamichi
Koeda, Mai
Yoshida, Yuji
Tanabe, Tomohide
Okubo, Tomomi
Hayama, Korenobu
Iwashita, Ai
Itokawa, Norio
Kondo, Chisa
Kaneko, Keiko
Kawamoto, Chiaki
Hatori, Tsutomu
Emoto, Naoya
Iio, Etsuko
Tanaka, Yasuhito
Iwakiri, Katsuhiko
description Although the presence of nonalcoholic fatty liver disease (NAFLD) is known to be related to subclinical atherosclerosis, the relationship between the severity of NAFLD and subclinical atherosclerosis is not clear. This study aimed to clarify the factors related to subclinical arteriosclerosis, including the histopathological severity of the disease and PNPLA3 gene polymorphisms, in NAFLD patients. We measured brachial-ankle pulse wave velocity (baPWV) as an index of arterial stiffness in 153 biopsy-proven NAFLD patients. The baPWV values were significantly higher in the advanced fibrosis group than in the less advanced group (median, 1679 cm/s vs 1489 cm/s; p = 5.49×10-4). Multiple logistic regression analysis revealed that older age (≥55 years) (p = 8.57×10-3; OR = 3.03), hypertension (p = 1.05×10-3; OR = 3.46), and advanced fibrosis (p = 9.22×10-3; OR = 2.94) were independently linked to baPWV ≥1600 cm/s. NAFLD patients were categorized into low-risk group (number of risk factors = 0), intermediate-risk group (= 1), and high-risk group (≥2) based on their risk factors, including older age, hypertension, and biopsy-confirmed advanced fibrosis. The prevalence of baPWV ≥1600 cm/s was 7.1% (3/42) in the low-risk group, 30.8% (12/39) in the intermediate-risk group, and 63.9% (46/72) in the high-risk group. Non-invasive liver fibrosis markers and scores, including the FIB-4 index, NAFLD fibrosis score, hyaluronic acid, Wisteria floribunda agglutinin positive Mac-2-binding protein, and type IV collagen 7s, were feasible substitutes for invasive liver biopsy. Older age, hypertension, and advanced fibrosis are independently related to arterial stiffness, and a combination of these three factors may predict risk of arteriosclerosis in NAFLD patients.
doi_str_mv 10.1371/journal.pone.0224184
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2314313189</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A605688452</galeid><doaj_id>oai_doaj_org_article_dad3abdfa6874df7b2b836661d2abfa5</doaj_id><sourcerecordid>A605688452</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-242e888eaa0d2d80d5058af76d94e001bf6a9584fdf43101d25536bffdd402ca3</originalsourceid><addsrcrecordid>eNqNk1trFDEUxwdRbK1-A9EBQfRh11xmMtkXoRSrC4WCt9dwJpedlOxkm2RW99ubdadlR_oggSQkv_M_l-QUxUuM5pg2-MONH0IPbr7xvZ4jQirMq0fFKV5QMmME0cdH-5PiWYw3CNWUM_a0OKG4Ibhp0GnhL0EmH2Jpe-MG3Uvbr8o4tNLZ3kpwJaROBx-l2892z5UbSFb3KZa_bOrK1vpN3M02wW91X_Y-xyR9552VpYGUdqWzWx1KZaOGqJ8XTwy4qF-M61nx4_LT94svs6vrz8uL86uZZAuSZqQimnOuAZAiiiNVo5qDaZhaVBoh3BoGi5pXRpmKYoQVqWvKWmOUqhCRQM-K1wfdjfNRjLWKglCceYr5IhPLA6E83IhNsGsIO-HBir8HPqwEhGRz4kKBotAqA4w3lTJNS1pOGWPZLbQG6qz1cfQ2tGutZK5OADcRnd70thMrvxWM57BRkwXejQLB3w46JrG2UWrnoNd-OMRd16ThLKNv_kEfzm6kVpATyI_rs1-5FxXnDNWM86ommZo_QOWh9NrK_LGMzecTg_cTg8wk_TutYIhRLL99_X_2-ueUfXvEdhpc6qJ3Q7K-j1OwOoAyf8cYtLkvMkZi3xd31RD7vhBjX2SzV8cPdG901wj0D3JaC0s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314313189</pqid></control><display><type>article</type><title>Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Arai, Taeang ; Atsukawa, Masanori ; Tsubota, Akihito ; Kawano, Tadamichi ; Koeda, Mai ; Yoshida, Yuji ; Tanabe, Tomohide ; Okubo, Tomomi ; Hayama, Korenobu ; Iwashita, Ai ; Itokawa, Norio ; Kondo, Chisa ; Kaneko, Keiko ; Kawamoto, Chiaki ; Hatori, Tsutomu ; Emoto, Naoya ; Iio, Etsuko ; Tanaka, Yasuhito ; Iwakiri, Katsuhiko</creator><contributor>Huang, Jee-Fu</contributor><creatorcontrib>Arai, Taeang ; Atsukawa, Masanori ; Tsubota, Akihito ; Kawano, Tadamichi ; Koeda, Mai ; Yoshida, Yuji ; Tanabe, Tomohide ; Okubo, Tomomi ; Hayama, Korenobu ; Iwashita, Ai ; Itokawa, Norio ; Kondo, Chisa ; Kaneko, Keiko ; Kawamoto, Chiaki ; Hatori, Tsutomu ; Emoto, Naoya ; Iio, Etsuko ; Tanaka, Yasuhito ; Iwakiri, Katsuhiko ; Huang, Jee-Fu</creatorcontrib><description>Although the presence of nonalcoholic fatty liver disease (NAFLD) is known to be related to subclinical atherosclerosis, the relationship between the severity of NAFLD and subclinical atherosclerosis is not clear. This study aimed to clarify the factors related to subclinical arteriosclerosis, including the histopathological severity of the disease and PNPLA3 gene polymorphisms, in NAFLD patients. We measured brachial-ankle pulse wave velocity (baPWV) as an index of arterial stiffness in 153 biopsy-proven NAFLD patients. The baPWV values were significantly higher in the advanced fibrosis group than in the less advanced group (median, 1679 cm/s vs 1489 cm/s; p = 5.49×10-4). Multiple logistic regression analysis revealed that older age (≥55 years) (p = 8.57×10-3; OR = 3.03), hypertension (p = 1.05×10-3; OR = 3.46), and advanced fibrosis (p = 9.22×10-3; OR = 2.94) were independently linked to baPWV ≥1600 cm/s. NAFLD patients were categorized into low-risk group (number of risk factors = 0), intermediate-risk group (= 1), and high-risk group (≥2) based on their risk factors, including older age, hypertension, and biopsy-confirmed advanced fibrosis. The prevalence of baPWV ≥1600 cm/s was 7.1% (3/42) in the low-risk group, 30.8% (12/39) in the intermediate-risk group, and 63.9% (46/72) in the high-risk group. Non-invasive liver fibrosis markers and scores, including the FIB-4 index, NAFLD fibrosis score, hyaluronic acid, Wisteria floribunda agglutinin positive Mac-2-binding protein, and type IV collagen 7s, were feasible substitutes for invasive liver biopsy. Older age, hypertension, and advanced fibrosis are independently related to arterial stiffness, and a combination of these three factors may predict risk of arteriosclerosis in NAFLD patients.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0224184</identifier><identifier>PMID: 31721770</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Age ; Age Factors ; Aged ; Aged, 80 and over ; Alcohol use ; Analysis ; Ankle ; Ankle Brachial Index ; Arteriosclerosis ; Atherosclerosis ; Atherosclerosis - complications ; Atherosclerosis - diagnosis ; Atherosclerosis - genetics ; Atherosclerosis - pathology ; Biology and Life Sciences ; Biopsy ; Blood pressure ; Cardiovascular disease ; Care and treatment ; Cholesterol ; Collagen ; Collagen (type IV) ; Diabetes ; Fatty liver ; Female ; Fibrosis ; Gastroenterology ; Genes ; Genetic aspects ; Genetic polymorphisms ; Health risks ; Hepatitis ; Hepatology ; Hospitals ; Humans ; Hyaluronic acid ; Hypertension ; Hypertension - complications ; Hypertension - genetics ; Laboratories ; Lipase - genetics ; Liver ; Liver diseases ; Male ; Medical research ; Medical schools ; Medicine and Health Sciences ; Membrane Proteins - genetics ; Metabolism ; Middle Aged ; Non-alcoholic Fatty Liver Disease - complications ; Non-alcoholic Fatty Liver Disease - diagnosis ; Non-alcoholic Fatty Liver Disease - genetics ; Non-alcoholic Fatty Liver Disease - pathology ; Protein binding ; Pulse Wave Analysis ; Regression analysis ; Risk analysis ; Risk Factors ; Risk groups ; Severity of Illness Index ; Stiffness ; Studies ; Type 2 diabetes ; Vascular Stiffness - physiology ; Virology ; Wave velocity ; Young Adult</subject><ispartof>PloS one, 2019-11, Vol.14 (11), p.e0224184-e0224184</ispartof><rights>COPYRIGHT 2019 Public Library of Science</rights><rights>2019 Arai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 Arai et al 2019 Arai et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-242e888eaa0d2d80d5058af76d94e001bf6a9584fdf43101d25536bffdd402ca3</citedby><cites>FETCH-LOGICAL-c692t-242e888eaa0d2d80d5058af76d94e001bf6a9584fdf43101d25536bffdd402ca3</cites><orcidid>0000-0003-3374-7111</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853607/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853607/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,2106,2932,23875,27933,27934,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31721770$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Huang, Jee-Fu</contributor><creatorcontrib>Arai, Taeang</creatorcontrib><creatorcontrib>Atsukawa, Masanori</creatorcontrib><creatorcontrib>Tsubota, Akihito</creatorcontrib><creatorcontrib>Kawano, Tadamichi</creatorcontrib><creatorcontrib>Koeda, Mai</creatorcontrib><creatorcontrib>Yoshida, Yuji</creatorcontrib><creatorcontrib>Tanabe, Tomohide</creatorcontrib><creatorcontrib>Okubo, Tomomi</creatorcontrib><creatorcontrib>Hayama, Korenobu</creatorcontrib><creatorcontrib>Iwashita, Ai</creatorcontrib><creatorcontrib>Itokawa, Norio</creatorcontrib><creatorcontrib>Kondo, Chisa</creatorcontrib><creatorcontrib>Kaneko, Keiko</creatorcontrib><creatorcontrib>Kawamoto, Chiaki</creatorcontrib><creatorcontrib>Hatori, Tsutomu</creatorcontrib><creatorcontrib>Emoto, Naoya</creatorcontrib><creatorcontrib>Iio, Etsuko</creatorcontrib><creatorcontrib>Tanaka, Yasuhito</creatorcontrib><creatorcontrib>Iwakiri, Katsuhiko</creatorcontrib><title>Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Although the presence of nonalcoholic fatty liver disease (NAFLD) is known to be related to subclinical atherosclerosis, the relationship between the severity of NAFLD and subclinical atherosclerosis is not clear. This study aimed to clarify the factors related to subclinical arteriosclerosis, including the histopathological severity of the disease and PNPLA3 gene polymorphisms, in NAFLD patients. We measured brachial-ankle pulse wave velocity (baPWV) as an index of arterial stiffness in 153 biopsy-proven NAFLD patients. The baPWV values were significantly higher in the advanced fibrosis group than in the less advanced group (median, 1679 cm/s vs 1489 cm/s; p = 5.49×10-4). Multiple logistic regression analysis revealed that older age (≥55 years) (p = 8.57×10-3; OR = 3.03), hypertension (p = 1.05×10-3; OR = 3.46), and advanced fibrosis (p = 9.22×10-3; OR = 2.94) were independently linked to baPWV ≥1600 cm/s. NAFLD patients were categorized into low-risk group (number of risk factors = 0), intermediate-risk group (= 1), and high-risk group (≥2) based on their risk factors, including older age, hypertension, and biopsy-confirmed advanced fibrosis. The prevalence of baPWV ≥1600 cm/s was 7.1% (3/42) in the low-risk group, 30.8% (12/39) in the intermediate-risk group, and 63.9% (46/72) in the high-risk group. Non-invasive liver fibrosis markers and scores, including the FIB-4 index, NAFLD fibrosis score, hyaluronic acid, Wisteria floribunda agglutinin positive Mac-2-binding protein, and type IV collagen 7s, were feasible substitutes for invasive liver biopsy. Older age, hypertension, and advanced fibrosis are independently related to arterial stiffness, and a combination of these three factors may predict risk of arteriosclerosis in NAFLD patients.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alcohol use</subject><subject>Analysis</subject><subject>Ankle</subject><subject>Ankle Brachial Index</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis - complications</subject><subject>Atherosclerosis - diagnosis</subject><subject>Atherosclerosis - genetics</subject><subject>Atherosclerosis - pathology</subject><subject>Biology and Life Sciences</subject><subject>Biopsy</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Cholesterol</subject><subject>Collagen</subject><subject>Collagen (type IV)</subject><subject>Diabetes</subject><subject>Fatty liver</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Gastroenterology</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genetic polymorphisms</subject><subject>Health risks</subject><subject>Hepatitis</subject><subject>Hepatology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hyaluronic acid</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - genetics</subject><subject>Laboratories</subject><subject>Lipase - genetics</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical schools</subject><subject>Medicine and Health Sciences</subject><subject>Membrane Proteins - genetics</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>Non-alcoholic Fatty Liver Disease - complications</subject><subject>Non-alcoholic Fatty Liver Disease - diagnosis</subject><subject>Non-alcoholic Fatty Liver Disease - genetics</subject><subject>Non-alcoholic Fatty Liver Disease - pathology</subject><subject>Protein binding</subject><subject>Pulse Wave Analysis</subject><subject>Regression analysis</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Risk groups</subject><subject>Severity of Illness Index</subject><subject>Stiffness</subject><subject>Studies</subject><subject>Type 2 diabetes</subject><subject>Vascular Stiffness - physiology</subject><subject>Virology</subject><subject>Wave velocity</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1trFDEUxwdRbK1-A9EBQfRh11xmMtkXoRSrC4WCt9dwJpedlOxkm2RW99ubdadlR_oggSQkv_M_l-QUxUuM5pg2-MONH0IPbr7xvZ4jQirMq0fFKV5QMmME0cdH-5PiWYw3CNWUM_a0OKG4Ibhp0GnhL0EmH2Jpe-MG3Uvbr8o4tNLZ3kpwJaROBx-l2892z5UbSFb3KZa_bOrK1vpN3M02wW91X_Y-xyR9552VpYGUdqWzWx1KZaOGqJ8XTwy4qF-M61nx4_LT94svs6vrz8uL86uZZAuSZqQimnOuAZAiiiNVo5qDaZhaVBoh3BoGi5pXRpmKYoQVqWvKWmOUqhCRQM-K1wfdjfNRjLWKglCceYr5IhPLA6E83IhNsGsIO-HBir8HPqwEhGRz4kKBotAqA4w3lTJNS1pOGWPZLbQG6qz1cfQ2tGutZK5OADcRnd70thMrvxWM57BRkwXejQLB3w46JrG2UWrnoNd-OMRd16ThLKNv_kEfzm6kVpATyI_rs1-5FxXnDNWM86ommZo_QOWh9NrK_LGMzecTg_cTg8wk_TutYIhRLL99_X_2-ueUfXvEdhpc6qJ3Q7K-j1OwOoAyf8cYtLkvMkZi3xd31RD7vhBjX2SzV8cPdG901wj0D3JaC0s</recordid><startdate>20191113</startdate><enddate>20191113</enddate><creator>Arai, Taeang</creator><creator>Atsukawa, Masanori</creator><creator>Tsubota, Akihito</creator><creator>Kawano, Tadamichi</creator><creator>Koeda, Mai</creator><creator>Yoshida, Yuji</creator><creator>Tanabe, Tomohide</creator><creator>Okubo, Tomomi</creator><creator>Hayama, Korenobu</creator><creator>Iwashita, Ai</creator><creator>Itokawa, Norio</creator><creator>Kondo, Chisa</creator><creator>Kaneko, Keiko</creator><creator>Kawamoto, Chiaki</creator><creator>Hatori, Tsutomu</creator><creator>Emoto, Naoya</creator><creator>Iio, Etsuko</creator><creator>Tanaka, Yasuhito</creator><creator>Iwakiri, Katsuhiko</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3374-7111</orcidid></search><sort><creationdate>20191113</creationdate><title>Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease</title><author>Arai, Taeang ; Atsukawa, Masanori ; Tsubota, Akihito ; Kawano, Tadamichi ; Koeda, Mai ; Yoshida, Yuji ; Tanabe, Tomohide ; Okubo, Tomomi ; Hayama, Korenobu ; Iwashita, Ai ; Itokawa, Norio ; Kondo, Chisa ; Kaneko, Keiko ; Kawamoto, Chiaki ; Hatori, Tsutomu ; Emoto, Naoya ; Iio, Etsuko ; Tanaka, Yasuhito ; Iwakiri, Katsuhiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-242e888eaa0d2d80d5058af76d94e001bf6a9584fdf43101d25536bffdd402ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alcohol use</topic><topic>Analysis</topic><topic>Ankle</topic><topic>Ankle Brachial Index</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis - complications</topic><topic>Atherosclerosis - diagnosis</topic><topic>Atherosclerosis - genetics</topic><topic>Atherosclerosis - pathology</topic><topic>Biology and Life Sciences</topic><topic>Biopsy</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Cholesterol</topic><topic>Collagen</topic><topic>Collagen (type IV)</topic><topic>Diabetes</topic><topic>Fatty liver</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Gastroenterology</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genetic polymorphisms</topic><topic>Health risks</topic><topic>Hepatitis</topic><topic>Hepatology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hyaluronic acid</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - genetics</topic><topic>Laboratories</topic><topic>Lipase - genetics</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical schools</topic><topic>Medicine and Health Sciences</topic><topic>Membrane Proteins - genetics</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>Non-alcoholic Fatty Liver Disease - complications</topic><topic>Non-alcoholic Fatty Liver Disease - diagnosis</topic><topic>Non-alcoholic Fatty Liver Disease - genetics</topic><topic>Non-alcoholic Fatty Liver Disease - pathology</topic><topic>Protein binding</topic><topic>Pulse Wave Analysis</topic><topic>Regression analysis</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Risk groups</topic><topic>Severity of Illness Index</topic><topic>Stiffness</topic><topic>Studies</topic><topic>Type 2 diabetes</topic><topic>Vascular Stiffness - physiology</topic><topic>Virology</topic><topic>Wave velocity</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arai, Taeang</creatorcontrib><creatorcontrib>Atsukawa, Masanori</creatorcontrib><creatorcontrib>Tsubota, Akihito</creatorcontrib><creatorcontrib>Kawano, Tadamichi</creatorcontrib><creatorcontrib>Koeda, Mai</creatorcontrib><creatorcontrib>Yoshida, Yuji</creatorcontrib><creatorcontrib>Tanabe, Tomohide</creatorcontrib><creatorcontrib>Okubo, Tomomi</creatorcontrib><creatorcontrib>Hayama, Korenobu</creatorcontrib><creatorcontrib>Iwashita, Ai</creatorcontrib><creatorcontrib>Itokawa, Norio</creatorcontrib><creatorcontrib>Kondo, Chisa</creatorcontrib><creatorcontrib>Kaneko, Keiko</creatorcontrib><creatorcontrib>Kawamoto, Chiaki</creatorcontrib><creatorcontrib>Hatori, Tsutomu</creatorcontrib><creatorcontrib>Emoto, Naoya</creatorcontrib><creatorcontrib>Iio, Etsuko</creatorcontrib><creatorcontrib>Tanaka, Yasuhito</creatorcontrib><creatorcontrib>Iwakiri, Katsuhiko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arai, Taeang</au><au>Atsukawa, Masanori</au><au>Tsubota, Akihito</au><au>Kawano, Tadamichi</au><au>Koeda, Mai</au><au>Yoshida, Yuji</au><au>Tanabe, Tomohide</au><au>Okubo, Tomomi</au><au>Hayama, Korenobu</au><au>Iwashita, Ai</au><au>Itokawa, Norio</au><au>Kondo, Chisa</au><au>Kaneko, Keiko</au><au>Kawamoto, Chiaki</au><au>Hatori, Tsutomu</au><au>Emoto, Naoya</au><au>Iio, Etsuko</au><au>Tanaka, Yasuhito</au><au>Iwakiri, Katsuhiko</au><au>Huang, Jee-Fu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2019-11-13</date><risdate>2019</risdate><volume>14</volume><issue>11</issue><spage>e0224184</spage><epage>e0224184</epage><pages>e0224184-e0224184</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Although the presence of nonalcoholic fatty liver disease (NAFLD) is known to be related to subclinical atherosclerosis, the relationship between the severity of NAFLD and subclinical atherosclerosis is not clear. This study aimed to clarify the factors related to subclinical arteriosclerosis, including the histopathological severity of the disease and PNPLA3 gene polymorphisms, in NAFLD patients. We measured brachial-ankle pulse wave velocity (baPWV) as an index of arterial stiffness in 153 biopsy-proven NAFLD patients. The baPWV values were significantly higher in the advanced fibrosis group than in the less advanced group (median, 1679 cm/s vs 1489 cm/s; p = 5.49×10-4). Multiple logistic regression analysis revealed that older age (≥55 years) (p = 8.57×10-3; OR = 3.03), hypertension (p = 1.05×10-3; OR = 3.46), and advanced fibrosis (p = 9.22×10-3; OR = 2.94) were independently linked to baPWV ≥1600 cm/s. NAFLD patients were categorized into low-risk group (number of risk factors = 0), intermediate-risk group (= 1), and high-risk group (≥2) based on their risk factors, including older age, hypertension, and biopsy-confirmed advanced fibrosis. The prevalence of baPWV ≥1600 cm/s was 7.1% (3/42) in the low-risk group, 30.8% (12/39) in the intermediate-risk group, and 63.9% (46/72) in the high-risk group. Non-invasive liver fibrosis markers and scores, including the FIB-4 index, NAFLD fibrosis score, hyaluronic acid, Wisteria floribunda agglutinin positive Mac-2-binding protein, and type IV collagen 7s, were feasible substitutes for invasive liver biopsy. Older age, hypertension, and advanced fibrosis are independently related to arterial stiffness, and a combination of these three factors may predict risk of arteriosclerosis in NAFLD patients.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>31721770</pmid><doi>10.1371/journal.pone.0224184</doi><tpages>e0224184</tpages><orcidid>https://orcid.org/0000-0003-3374-7111</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2019-11, Vol.14 (11), p.e0224184-e0224184
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2314313189
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS) Journals Open Access; PubMed Central; Free Full-Text Journals in Chemistry
subjects Adolescent
Adult
Age
Age Factors
Aged
Aged, 80 and over
Alcohol use
Analysis
Ankle
Ankle Brachial Index
Arteriosclerosis
Atherosclerosis
Atherosclerosis - complications
Atherosclerosis - diagnosis
Atherosclerosis - genetics
Atherosclerosis - pathology
Biology and Life Sciences
Biopsy
Blood pressure
Cardiovascular disease
Care and treatment
Cholesterol
Collagen
Collagen (type IV)
Diabetes
Fatty liver
Female
Fibrosis
Gastroenterology
Genes
Genetic aspects
Genetic polymorphisms
Health risks
Hepatitis
Hepatology
Hospitals
Humans
Hyaluronic acid
Hypertension
Hypertension - complications
Hypertension - genetics
Laboratories
Lipase - genetics
Liver
Liver diseases
Male
Medical research
Medical schools
Medicine and Health Sciences
Membrane Proteins - genetics
Metabolism
Middle Aged
Non-alcoholic Fatty Liver Disease - complications
Non-alcoholic Fatty Liver Disease - diagnosis
Non-alcoholic Fatty Liver Disease - genetics
Non-alcoholic Fatty Liver Disease - pathology
Protein binding
Pulse Wave Analysis
Regression analysis
Risk analysis
Risk Factors
Risk groups
Severity of Illness Index
Stiffness
Studies
Type 2 diabetes
Vascular Stiffness - physiology
Virology
Wave velocity
Young Adult
title Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T16%3A43%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20influencing%20subclinical%20atherosclerosis%20in%20patients%20with%20biopsy-proven%20nonalcoholic%20fatty%20liver%20disease&rft.jtitle=PloS%20one&rft.au=Arai,%20Taeang&rft.date=2019-11-13&rft.volume=14&rft.issue=11&rft.spage=e0224184&rft.epage=e0224184&rft.pages=e0224184-e0224184&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0224184&rft_dat=%3Cgale_plos_%3EA605688452%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2314313189&rft_id=info:pmid/31721770&rft_galeid=A605688452&rft_doaj_id=oai_doaj_org_article_dad3abdfa6874df7b2b836661d2abfa5&rfr_iscdi=true